Literature DB >> 16773701

Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma.

Muriel Mathonnet, Bernard Descottes, Denis Valleix, Francois Labrousse, Veronique Truffinet, Yves Denizot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16773701      PMCID： PMC4087477          DOI： 10.3748/wjg.v12.i23.3782

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  7 in total

1.  The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

Authors:  O N El-Assal; A Yamanoi; T Ono; H Kohno; N Nagasue
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues.

Authors:  Muriel Mathonnet; Bernard Descottes; Denis Valleix; François Labrousse; Yves Denizot
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

Review 3.  Role of soluble mediators in angiogenesis.

Authors:  F Bussolino; A Albini; G Camussi; M Presta; G Viglietto; M Ziche; G Persico
Journal:  Eur J Cancer       Date:  1996-12       Impact factor: 9.162

4.  Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.

Authors:  Terence-C Tang; Ronnie-T Poon; Cecilia-P Lau; Dan Xie; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

5.  Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

6.  Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.

Authors:  Geertu Deli; Can-Hao Jin; Rong Mu; Song Yang; Yue Liang; De Chen; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

7.  Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer.

Authors:  M Landriscina; A Cassano; C Ratto; R Longo; M Ippoliti; B Palazzotti; F Crucitti; C Barone
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640
  7 in total
  8 in total

1.  IGF-1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolization.

Authors:  Yongxu Mu; Junfeng He; Ruiqiang Yan; Xiaoyan Hu; Haiyan Liu; Zhiming Hao
Journal:  Exp Ther Med       Date:  2015-12-08       Impact factor: 2.447

2.  Anti-angiogenic and anti-proliferative effects of inhibition of HIF-1α by p-HIF-1α RNAi in colorectal cancer.

Authors:  Yan-Yan Qiu; Song-Jiao Hu; Yi-Jie Bao; Bo Liang; Cui-Na Yan; Xiao-Jing Shi; Hui Yu; Yu Zou; Li-Rui Tang; Qing-Feng Tang; Wen Feng; Pei-Hao Yin
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

3.  Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis.

Authors:  Leida Zhang; Peng Hu; Xi Chen; Ping Bie
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

4.  Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis.

Authors:  Jinbin Chen; Shixun Lu; Yaojun Zhang; Li Xu; Jiancong Chen; Juncheng Wang; Minshan Chen; Rongxin Zhang; Zhongguo Zhou
Journal:  J Cancer       Date:  2018-04-19       Impact factor: 4.207

5.  Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.

Authors:  Jing Chen; Chengya Zhou; Yu Long; Xude Yin
Journal:  Tumour Biol       Date:  2014-09-14

6.  The Quantitative analysis of bFGF and VEGF by ELISA in human meningiomas.

Authors:  Yves Denizot; Rafael De Armas; François Caire; Jean Jacques Moreau; Isabelle Pommepuy; Véronique Truffinet; François Labrousse
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 7.  Tissue Specific Promoters in Colorectal Cancer.

Authors:  A R Rama; A Aguilera; C Melguizo; O Caba; J Prados
Journal:  Dis Markers       Date:  2015-11-15       Impact factor: 3.434

8.  The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis.

Authors:  Zhoujing Cheng; Lin He; Yingjie Guo; Yuhua Song; Shasha Song; Lijiu Zhang
Journal:  World J Surg Oncol       Date:  2020-09-11       Impact factor: 2.754
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.